Collin J Christensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Collin J Christensen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Brian Gebelein
Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication Brittany Cain
Engineering, University of Cincinnati, Cincinnati, United States
1 shared publication- David Sprinzak
School of Neurobiology, Biochemistry & Biophysics, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
1 shared publication FearGod V Okwubido-Williams
Engineering, University of Cincinnati, Cincinnati, United States
1 shared publicationIan Campbell
Engineering, University of Cincinnati, Cincinnati, United States
1 shared publicationJoseph Salomone
Pediatrics - Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
1 shared publication
Latest Publications
- Open Access
- 16 April 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Enhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism
Notch pathway haploinsufficiency can cause severe developmental syndromes with highly variable penetrance. Currently, we have a limited mechanistic understanding of phenotype variability due to gene dosage. Here, we unexpectedly found that inserting an enhancer containing pioneer transcription factor sites coupled to Notch dimer sites can induce a subset of Notch haploinsufficiency phenotypes in Drosophila with wild type Notch gene dose. Using Drosophila genetics, we show that this enhancer induces Notch phenotypes in a Cdk8-dependent, transcription-independent manner. We further combined mathematical modeling with quantitative trait and expression analysis to build a model that describes how changes in Notch signal production versus degradation differentially impact cellular outcomes that require long versus short signal duration. Altogether, these findings support a ‘bind and discard’ mechanism in which enhancers with specific binding sites promote rapid Cdk8-dependent Notch turnover, and thereby reduce Notch-dependent transcription at other loci and sensitize tissues to gene dose based upon signal duration.
- 16 April 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessEnhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism
Notch pathway haploinsufficiency can cause severe developmental syndromes with highly variable penetrance. Currently, we have a limited mechanistic understanding of phenotype variability due to gene dosage. Here, we unexpectedly found that inserting an enhancer containing pioneer transcription factor sites coupled to Notch dimer sites can induce a subset of Notch haploinsufficiency phenotypes in Drosophila with wild type Notch gene dose. Using Drosophila genetics, we show that this enhancer induces Notch phenotypes in a Cdk8-dependent, transcription-independent manner. We further combined mathematical modeling with quantitative trait and expression analysis to build a model that describes how changes in Notch signal production versus degradation differentially impact cellular outcomes that require long versus short signal duration. Altogether, these findings support a ‘bind and discard’ mechanism in which enhancers with specific binding sites promote rapid Cdk8-dependent Notch turnover, and thereby reduce Notch-dependent transcription at other loci and sensitize tissues to gene dose based upon signal duration.